Ardelyx, Inc. (ARDX) financial statements (2022 and earlier)

Company profile

Business Address 34175 ARDENWOOD BLVD.
FREMONT, CA 94555
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:116,689186,484247,492168,127134,023200,894107,004
Cash and cash equivalents72,42891,032181,13378,76875,38374,598107,004
Short-term investments44,26195,45266,37989,32158,593126,225 
Other undisclosed cash, cash equivalents, and short-term investments  (20)384771 
Receivables502      
Contract with customer, asset  750 
Other undisclosed current assets16,4588,2023,8208,24415,6893,0985,027
Total current assets:133,649194,686252,062176,371149,712203,992112,031
Noncurrent Assets
Operating lease, right-of-use asset12,7522,2743,970
Property, plant and equipment2,3621,9363,4365,6118,0328,9914,711
Long-term investments and receivables 2,114     
Long-term investments 2,114     
Restricted cash and investments      100
Other noncurrent assets1,1505523141,350159148104
Total noncurrent assets:16,2646,8767,7206,9618,1919,1394,915
TOTAL ASSETS:149,913201,562259,782183,332157,903213,131116,946
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,90211,2986,64016,72817,8718,7965,143
Accounts payable4,2775,6262,1871,1483,9335,6352,777
Accrued liabilities   12,85710,709  
Employee-related liabilities5,4225,6724,4532,7233,2293,1612,366
Interest and dividends payable203      
Debt32,2646,2843,791    
Other liabilities605285749  684 
Other undisclosed current liabilities10,05010,54911,0401,000 9,7212,580
Total current liabilities:52,82128,41622,22017,72817,87119,2017,723
Noncurrent Liabilities
Long-term debt and lease obligation9,74847,03450,90749,209   
Long-term debt, excluding current maturities 46,62148,83149,209   
Operating lease, liability9,7484132,076
Liabilities, other than long-term debt4,727    779322
Deferred revenue4,727  
Other liabilities     779322
Other undisclosed noncurrent liabilities   (48,627)720  
Total noncurrent liabilities:14,47547,03450,907582720779322
Other undisclosed liabilities   49,209   
Total liabilities:67,29675,45073,12767,51918,59119,9808,045
Stockholders' equity
Stockholders' equity attributable to parent82,617126,112186,655115,813139,312193,151108,901
Common stock13996553
Additional paid in capital795,540680,872647,078481,357417,568407,092210,386
Accumulated other comprehensive income (loss)(6)(4)20(38)(47)(71) 
Accumulated deficit(712,930)(554,765)(460,452)(365,512)(278,214)(213,875)(101,488)
Total stockholders' equity:82,617126,112186,655115,813139,312193,151108,901
TOTAL LIABILITIES AND EQUITY:149,913201,562259,782183,332157,903213,131116,946

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues10,0977,5715,2812,60742,000 24,026
Revenue, net42,000 24,026
Cost of revenue(1,000)(145)(600)(466)(8,400)(100)(100)
Financial services costs(100)(100)(100)(100)
Gross profit:9,0977,4264,6812,14133,600(100)23,926
Operating expenses(163,443)(98,206)(95,944)(93,088)(98,715)(112,895)(53,415)
Other undisclosed operating income     100100
Operating loss:(154,346)(90,780)(91,263)(90,947)(65,115)(112,895)(29,389)
Nonoperating income (expense)6871,5682,3523,1871,955508(261)
Other nonoperating expense      (261)
Interest and debt expense(4,502)(5,099)(5,726)(3,534)(375)(346)(351)
Loss from continuing operations before equity method investments, income taxes:(158,161)(94,311)(94,637)(91,294)(63,535)(112,733)(30,001)
Other undisclosed income from continuing operations before income taxes    375346351
Loss from continuing operations before income taxes:(158,161)(94,311)(94,637)(91,294)(63,160)(112,387)(29,650)
Income tax expense (benefit)(4)(2)(303)(4)(1,179) 29
Net loss available to common stockholders, diluted:(158,165)(94,313)(94,940)(91,298)(64,339)(112,387)(29,621)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(158,165)(94,313)(94,940)(91,298)(64,339)(112,387)(29,621)
Comprehensive loss:(158,165)(94,313)(94,940)(91,298)(64,339)(112,387)(29,621)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2)(24)58924(71) 
Comprehensive loss, net of tax, attributable to parent:(158,167)(94,337)(94,882)(91,289)(64,315)(112,458)(29,621)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: